The SFGM-TC MDS score at day 180 is associated with post-transplant outcomes in patients with myelodysplastic syndrome who underwent CD34+ selected allogeneic stem cell transplant Meeting Abstract


Authors: Alarcon, A.; Hilden, P. D.; Maloy, M.; Ruiz, J. D.; Sanchez-Escamilla, M.; YaƱez, L.; Castillo, N.; Tamari, R.; Shaffer, B.; Castro-Malaspina, H.; Giralt, S.; Perales, M. A.
Abstract Title: The SFGM-TC MDS score at day 180 is associated with post-transplant outcomes in patients with myelodysplastic syndrome who underwent CD34+ selected allogeneic stem cell transplant
Meeting Title: 45th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT)
Journal Title: Bone Marrow Transplantation
Volume: 54
Issue: Suppl. 1
Meeting Dates: 2019 Mar 24-27
Meeting Location: Frankfurt, Germany
ISSN: 0268-3369
Publisher: Nature Publishing Group  
Date Published: 2019-07-03
Start Page: 511
End Page: 512
Language: English
ACCESSION: WOS:000487707800651
PROVIDER: wos
PUBMED: 31270396
DOI: 10.1038/s41409-019-0559-4
Notes: Meeting Abstract: P574 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work